RxDoctor Payments DataLook up a doctor →

Christopher McCarty, MD

Cardiovascular Disease · Ladson, SCNPI 1912916099

Payments from drug & device makers

$12,819in general payments, 2019–2025

Across 508 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Abbott$1K
  • Boston Scientific$913
  • E.r. Squibb & Sons, L.L.C.$893
  • Johnson & Johnson$841
  • AstraZeneca$623
  • plus $4K from 35 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)55$4,250
Abbott56$1,058
Boston Scientific31$913
E.r. Squibb & Sons, L.L.C.56$893
Johnson & Johnson50$841
AstraZeneca44$623
Amgen40$607
Novartis35$515
Boehringer Ingelheim22$388
Pfizer15$383
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)19$311
Abiomed5$277
Merck15$259
Shockwave Medical, Inc3$147
Livanova USA, Inc.1$134
Teleflex LLC5$122
Astellas Pharma US Inc6$114
Sanofi-aventis U.S. LLC5$98
Heartflow, Inc.1$96
Biotronik Inc.5$78
Lexicon Pharmaceuticals, Inc.4$75
Kiniksa Pharmaceuticals International, PLC3$62
Inari Medical, Inc.1$52
Edwards Lifesciences3$50
Kiniksa Pharmaceuticals, Ltd.3$49
Scpharmaceuticals Inc.2$41
Alnylam Pharmaceuticals Inc.2$41
Arbor Pharmaceuticals, Inc.3$39
Cvrx, Inc.2$38
Philips North America LLC1$34
Terumo Medical Corporation2$34
Preventice Services, LLC1$30
Bardy Diagnostics, Inc.2$29
Amarin Pharma, Inc.2$26
Atricure, Inc.1$20
Bayer1$18
Novo Nordisk1$17
Actelion Pharmaceuticals US, Inc.2$15
Kowa Pharmaceuticals America, Inc.1$13
Esperion Therapeutics, Inc.1$13
Regeneron Healthcare Solutions, Inc.1$12

How this compares

$12,819 in reported general payments places this provider in the 75th percentile of 257 cardiovascular disease providers in South Carolina.

See all cardiovascular disease providers in South Carolina →

Medicare billing

Part B allowed, 2024
$309,955
Medicare patients
879
Services billed
3,556

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Ladson

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →